Skip to main content
Table of Contents
Print

Are There Clinical Trials for Medical Cannabis in Anorexia Nervosa? 

Author: Dr. Clarissa Morton, PharmD

Interest in the role of cannabis for eating disorders is growing, but evidence remains limited. Researchers are beginning to conduct cannabis clinical trials for anorexia to evaluate whether cannabinoids can support appetite, reduce anxiety, and improve overall recovery outcomes. 

For patients, this research is vital in moving from anecdotal reports to scientifically validated treatment options. 

The Current State of Research 

So far, only a small number of studies have investigated cannabis in the context of anorexia, but more are emerging. 

Research Studies 

Ongoing research studies are testing both THC and CBD for their effects on appetite stimulation, mood regulation, and weight restoration in anorexia patients. 

Evidence-Based Medicine 

These trials aim to build evidence-based medicine by providing clinical data on safety, dosing, and treatment outcomes, areas where current knowledge is still limited. 

Treatment Evaluation 

Through treatment evaluation, researchers hope to clarify whether cannabis is best used as a complementary therapy alongside psychological and nutritional care. 

In summary, while cannabis clinical trials for anorexia are still at an early stage, they represent a critical step towards understanding its potential role in treatment. Patients and clinicians alike may benefit from clearer evidence in the coming years. 

Visit providers like LeafEase for updates on ongoing research into cannabis therapies for anorexia. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Anorexia. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories